...

Conference Report

Coverage of the 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV

Source: CCO Independent Conference Coverage of the 2004 International Workshop on Adverse Drug Reactions And Lipodystrophy in HIV*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Coverage of the 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV


Program Director: John P. Phair, MD

Faculty:

Judith S. Currier, MD, MScPeter Reiss, MD, PhD
  • Judith S. Currier, MD, MSc
  • Peter Reiss, MD, PhD

CREDIT INFORMATION

Release Date: December 13, 2004

Expiration Date: December 12, 2005


Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: The activity is not currently available for credit.

Begin the Conference Report

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review recent data regarding the adverse effects and metabolic perturbations associated with specific agents used in the treatment of HIV-infected patients

  • Describe insights into the pathogenesis of metabolic and morphologic abnormalities in HIV-infected patients

  • Discuss the results of studies of management strategies for metabolic complications and lipodystrophy in HIV-infected patients


Earn CME credit by reading summaries and expert commentary on our faculty's choice of the most clinically significant presentations. Topics covered include:

  • Implications of Antiretroviral Toxicity in the Developing World
  • Antiretroviral Therapy and Insulin Resistance: Data from MACS
  • Metabolic Changes During Intermittent Antiretroviral Therapy
  • Effects of PIs on Glucose Metabolism
  • Pre-eclampsia and Markers of Endothelial Dysfunction and Insulin Resistance
  • Pharmacology of NRTIs
  • Effects of Different NRTIs on Mitochondrial Depletion in Adipose Tissue
  • Treatment of Mitochondrial Toxicity
  • Neuroendocrine Regulation of Adipose Tissue Metabolism
  • Modified Lipodystrophy Case Definition
  • Treatment Options for Facial Lipoatrophy
  • Growth Hormone Releasing Factor Analogue for Treating Lipohypertrophy
Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.